Carmela Pinnetti

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

Journal: British journal of haematology

Published: April 22, 2026

Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT.

Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 06, 2026

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: January 20, 2026

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Journal: Brain : a journal of neurology

Published: December 30, 2025

Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study).

Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study).

Journal: Infectious diseases and therapy

Published: December 22, 2025

Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings.

Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings.

Journal: The Lancet. Infectious diseases

Published: December 13, 2025

Successful use of isavuconazole as secondary prophylaxis of cryptococcal meningitis in a person living with HIV and AIDS: a case report.

Successful use of isavuconazole as secondary prophylaxis of cryptococcal meningitis in a person living with HIV and AIDS: a case report.

Journal: Therapeutic advances in infectious disease

Published: June 11, 2025

Autophagy is influenced by vitamin D3 level in people with HIV-1.

Autophagy is influenced by vitamin D3 level in people with HIV-1.

Journal: Biology direct

Published: April 29, 2025

Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).

Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 11, 2025

Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments.

Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments.

Journal: The Journal of antimicrobial chemotherapy

Published: February 24, 2025

Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation.

Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 02, 2025

Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital.

Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital.

Journal: Vaccines

Published: August 03, 2024

Showing 1-12 of 135

Last Updated: 09/26/2026